Literature DB >> 7629390

Post-surgical follow-up of differentiated thyroid cancer.

F Pacini1, R Elisei, L Fugazzola, F Cetani, C Romei, F Mancusi, A Pinchera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629390     DOI： 10.1007/BF03349733

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

1.  Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy).

Authors:  F Pacini; A Pinchera; C Giani; L Grasso; L Baschieri
Journal:  Clin Endocrinol (Oxf)       Date:  1980-07       Impact factor: 3.478

2.  Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer.

Authors:  F Pacini; R Lari; S Mazzeo; L Grasso; D Taddei; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1985-10       Impact factor: 3.478

3.  Radioimmunoassay for measurement of thyroglobulin in human serum.

Authors:  A J Van Herle; R P Uller; N I Matthews; J Brown
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

4.  Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

Authors:  F Pacini; F Lippi; N Formica; R Elisei; S Anelli; C Ceccarelli; A Pinchera
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

5.  Serum thyroglobulin in thyroid carcinoma and other thyroid disorders.

Authors:  F Pacini; A Pinchera; C Giani; L Grasso; F Doveri; L Baschieri
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

6.  Serum thyroglobulin in the management of patients with thyroid cancer.

Authors:  C P Barsano; C Skosey; L J DeGroot; S Refetoff
Journal:  Arch Intern Med       Date:  1982-04

7.  The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer.

Authors:  M W Ashcraft; A J Van Herle
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965
  7 in total
  5 in total

1.  Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer.

Authors:  V Oliynyk; O Epshtein; T Sovenko; M Tronko; R Elisei; F Pacini; A Pinchera
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

2.  Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer.

Authors:  S Lisi; F Menconi; M A Altea; L Agate; E Molinaro; M G Castagna; D Taddei; L Grasso; A Pinchera; R Elisei; M Marinò
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

3.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Authors:  N Lima; H Cavaliere; E Tomimori; M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

4.  The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma.

Authors:  M G Castagna; H P Tala Jury; C Cipri; V Belardini; C Fioravanti; L Pasqui; F Sestini; A Theodoropoulou; F Pacini
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

5.  Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.

Authors:  A S Alzahrani; H Raef; A Sultan; S Al Sobhi; S Ingemansson; M Ahmed; A Al Mahfouz
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.